Pembrolizumab MK-3475 in combination with lenalidomide and low-dose dexamethasone for relapsed-refractory multiple myeloma RRMM: KEYNOTE-023Report as inadecuate




Pembrolizumab MK-3475 in combination with lenalidomide and low-dose dexamethasone for relapsed-refractory multiple myeloma RRMM: KEYNOTE-023 - Download this document for free, or read online. Document in PDF available to download.

Journal for ImmunoTherapy of Cancer

, 3:P160

First Online: 04 November 2015DOI: 10.1186-2051-1426-3-S2-P160

Cite this article as: Mateos, MV., Siegel, D., Shah, J.J. et al. j. immunotherapy cancer 2015 3Suppl 2: P160. doi:10.1186-2051-1426-3-S2-P160 Download fulltext PDF



Author: Maria-Victoria Mateos - David Siegel - Jatin J Shah - Donna Reece - David Avigan - Robert Orlowski - Yang Ge - Arun Balak

Source: https://link.springer.com/







Related documents